feed,title,long_url,short_url
BioRxiv,Persistent cross-species SARS-CoV-2 variant infectivity predicted via comparative molecular dynamics simulation,https://biorxiv.org/cgi/content/short/2022.04.18.488629v1?rss=1,https://bit.ly/3MyOWpt
BioRxiv,Redox regulation of the SARS-CoV-2 main protease provides new opportunities for drug design,https://biorxiv.org/cgi/content/short/2022.04.18.487732v1?rss=1,https://bit.ly/3EItpId
BioRxiv,Elucidating host cell response pathways and repurposing therapeutics for SARS-CoV-2 and other coronaviruses using gene expression profiles of chemical and genetic perturbations,https://biorxiv.org/cgi/content/short/2022.04.18.488682v1?rss=1,https://bit.ly/3jTWwhS
BioRxiv,Vγ9Vδ2 T cells are potent inhibitors of SARS-CoV-2 replication and exert effector phenotypes in COVID-19 patients,https://biorxiv.org/cgi/content/short/2022.04.15.487518v1?rss=1,https://bit.ly/3OA00V9
